Mirae Asset Global Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
254,504
+16,799
+7% +$1.12M 0.03% 340
2026
Q1
$14.9M Buy
237,705
+10,157
+4% +$707K 0.01% 328
2025
Q4
$15.1M Buy
227,548
+15,503
+7% +$1M 0.04% 322
2025
Q3
$14.3M Buy
212,045
+21,352
+11% +$1.69M 0.04% 311
2025
Q2
$16.6M Buy
190,693
+12,155
+7% +$953K 0.06% 257
2025
Q1
$12.1M Buy
178,538
+30,627
+21% +$2.5M 0.05% 286
2024
Q4
$11.8M Buy
147,911
+17,650
+14% +$1.31M 0.05% 274
2024
Q3
$8.77M Sell
130,261
-132,411
-50% -$10.9M 0.04% 315
2024
Q2
$30.1M Sell
262,672
-552,024
-68% -$69.8M 0.15% 115
2024
Q1
$100M Sell
814,696
-35,989
-4% -$4.52M 0.22% 88
2023
Q4
$106M Buy
850,685
+2,231
+0.3% +$228K 0.21% 100
2023
Q3
$78.2M Buy
848,454
+67,146
+9% +$7.57M 0.17% 134
2023
Q2
$100M Sell
781,308
-56,968
-7% -$6.89M 0.21% 88
2023
Q1
$97M Sell
838,276
-166,766
-17% -$18.7M 0.23% 84
2022
Q4
$114M Sell
1,005,042
-63,005
-6% -$6.92M 0.3% 62
2022
Q3
$86.3M Buy
1,068,047
+18,821
+2% +$1.59M 0.23% 86
2022
Q2
$78.2M Sell
1,049,226
-34,770
-3% -$3.17M 0.2% 111
2022
Q1
$139M Buy
1,083,996
+262,064
+32% +$28.7M 0.29% 60
2021
Q4
$111M Buy
821,932
+31,704
+4% +$4.56M 0.24% 87
2021
Q3
$108M Buy
790,228
+97,868
+14% +$12.3M 0.27% 75
2021
Q2
$73.9M Buy
692,360
+13,900
+2% +$1.33M 0.21% 116
2021
Q1
$61M Buy
678,460
+82,616
+14% +$7.76M 0.21% 115
2020
Q4
$55.1M Sell
595,844
-280,596
-32% -$25.1M 0.2% 117
2020
Q3
$89.3M Buy
876,440
+74,288
+9% +$7.76M 0.44% 40
2020
Q2
$81.3M Buy
802,152
+549,756
+218% +$49.2M 0.49% 36
2020
Q1
$17M Buy
252,396
+32,492
+15% +$2.02M 0.13% 159
2019
Q4
$12M Buy
219,904
+50,224
+30% +$2.38M 0.07% 310
2019
Q3
$6.33M Sell
169,680
-85,452
-33% -$3.32M 0.04% 418
2019
Q2
$9.56M Buy
255,132
+23,044
+10% +$724K 0.07% 310
2019
Q1
$6.91M Sell
232,088
-70,456
-23% -$2.48M 0.05% 343
2018
Q4
$9.06M Sell
302,544
-58,876
-16% -$1.87M 0.08% 259
2018
Q3
$12.9M Buy
+361,420
New +$11.2M 0.1% 218
2017
Q3
Sell
-99,600
Closed -$1.82M 661
2017
Q2
$1.82M Sell
99,600
-7,200
-7% -$133K 0.03% 326
2017
Q1
$2.26M Buy
106,800
+62,000
+138% +$1.21M 0.04% 255
2016
Q4
$668K Sell
44,800
-54,548
-55% -$966K 0.01% 365
2016
Q3
$2.18M Buy
99,348
+2,216
+2% +$49.3K 0.05% 237
2016
Q2
$1.93M Buy
+97,132
New +$1.65M 0.05% 219

Other funds holding DXCM

Mirae Asset Global Investments's DXCM Position: Q2 2026 in Review

Mirae Asset Global Investments increased its DexCom (DXCM) stake by 7.1% in Q2 2026, buying an estimated $1.12M and bringing the position to 254,504 shares worth $17.1M. The position accounts for 0.03% of the portfolio, ranked #340.

Mirae Asset Global Investments first reported a position in DXCM in Q2 2016 and has held it in 37 quarters since. The position peaked at $139M in Q1 2022. 429 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mirae Asset Global Investments held 254,504 shares of DexCom worth $17.1M as of Q2 2026.
  • Mirae Asset Global Investments bought 16,799 DexCom shares in Q2 2026, an estimated $1.12M.
  • DexCom made up 0.03% of Mirae Asset Global Investments's portfolio in Q2 2026, its #340 holding.
  • Mirae Asset Global Investments first reported a position in DexCom in Q2 2016 and has held it in 37 quarters since.
  • Mirae Asset Global Investments's DexCom position peaked at $139M in Q1 2022.
  • 429 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.